Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units

Burr, SE, Hart, J, Samikwa, L, Chaima, D, Cooley, G, Martin, D, Masika, M, Solomon, AW, Bailey, RLORCID logo and Kalua, K (2019). Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units. [Dataset]. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0007749
Copy

Following one to five years of antibiotic mass drug administration (MDA) for the elimination of trachoma as a public health problem, programmes must conduct impact surveys to inform decisions on whether MDA is still needed. These decisions are currently based on the prevalence of trachomatous inflammation—follicular (TF), which, after MDA, correlates poorly with prevalence of ocular Chlamydia trachomatis infection.

Keywords

World Health Organization, Pgp 3 seroprevalence, Chlamydia trachomatis infection, antibiotic mass drug administration, anti-Pgp 3 antibodies

No files available. Please consult associated links.


Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core (with Type as Type) MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON METS MODS RDF+N3 RDF+N-Triples RDF+XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads